Zur Rose Group AG
A European e-commerce pharmacy providing an online platform for medicines and health.
ROSE | SW
Overview
Corporate Details
- ISIN(s):
- CH0042615283 (+1 more)
- LEI:
- 50670038OH136R5Z4663
- Country:
- Switzerland
- Address:
- Walzmühlestrasse 49, 8500 Frauenfeld
- Sector:
- Wholesale and retail trade
Description
DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-21 02:00 |
DocMorris AG gibt das Ergebnis ihres Bezugsrechtsangebots bekannt
|
German | 12.1 KB | ||
| 2025-05-20 13:30 |
Pelion invests in DocMorris
|
English | 11.8 KB | ||
| 2025-05-14 09:00 |
DocMorris: Aktuelle Kantar-Verbraucherbefragung zeigt weiter steigende Beliebth…
|
German | 4.8 KB | ||
| 2025-05-09 20:28 |
DocMorris AG shareholders approve capital increase and all proposals put forwar…
|
English | 15.6 KB | ||
| 2025-05-08 06:58 |
DocMorris announces final details on the agenda of today's Annual General Meeti…
|
English | 23.0 KB | ||
| 2025-05-08 00:00 |
Quarterly Report Q1 2025
|
English | 129.6 KB | ||
| 2025-04-11 06:58 |
DocMorris accelerates Rx growth to 52 per cent and secures CHF 200 million capi…
|
English | 24.0 KB | ||
| 2025-04-10 06:00 |
(Incl. information on banking syndicate:) DocMorris accelerates Rx growth to 52…
|
English | 773 bytes | ||
| 2025-04-10 00:00 |
Q1/2025 trading update and Outlook presentation
|
English | 2.3 MB | ||
| 2025-03-14 06:58 |
DocMorris achieves 2024 targets, expects Rx growth of around 50 per cent in the…
|
English | 28.1 KB | ||
| 2025-03-14 00:00 |
Corporate Governance
|
English | 223.0 KB | ||
| 2025-03-14 00:00 |
Annual Report 2024
|
English | 1.9 MB | ||
| 2025-03-13 06:58 |
DocMorris achieves 2024 targets, expects Rx growth of around 50 per cent in the…
|
English | 28.1 KB | ||
| 2025-03-13 01:00 |
DocMorris achieves 2024 targets, expects Rx growth of around 50 per cent in the…
|
English | 25.2 KB | ||
| 2025-03-13 01:00 |
DocMorris erreicht Ziele 2024, erwartet ein Rx-Wachstum von rund 50 Prozent im …
|
German | 26.3 KB |
Automate Your Workflow. Get a real-time feed of all Zur Rose Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zur Rose Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zur Rose Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 175,188.00 CHF |
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 28,818.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 34,500.00 CHF |
| 2025-05-19 | N/A | Non-Executive member | Buy | None | 14,040.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 9,142.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 1,035,000.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 46,400.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 10,315.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 8,616.00 CHF |
| 2025-05-15 | N/A | Executive member | Buy | None | 678,770.25 CHF |
Peer Companies
